OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
November 18, 2021
Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.
November 12, 2021
Fujifilm is expanding its R&D footprint at its California facility.
November 02, 2021
The adoption of perfusion cell culture continues to advance with the help of PAT tools.
September 02, 2021
Advancements in bioprocessing technologies test microbial fermentation adaptability.
August 19, 2021
Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.
August 01, 2021
Automation is one asset that benefits cell harvesting by cutting out laborious manual steps and minimizing contamination.
July 20, 2021
The companies work to develop and supply advanced cell models that better reflect an in-vivo environment to improve drug discovery accuracy and efficiency.
June 02, 2021
Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production.
May 12, 2021
Originally established in the 1970s as a fetal bovine serum supplier, Fujifilm Irvine Scientific continuously proved its strength in the cell culture solutions space.
May 02, 2021
Demand for recombinant microorganism-based cell culture supplements is rising on the back of lower contamination risk.